Literature DB >> 10542295

Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation.

H Liénard1, P Bruhns, O Malbec, W H Fridman, M Daëron.   

Abstract

Signal regulatory proteins of the alpha subtype (SIRPalpha) are ubiquitous molecules of the immunoglobulin superfamily that negatively regulate protein tyrosine kinase receptor-dependent cell proliferation. Their intracytoplasmic domain contains four motifs that resemble immunoreceptor tyrosine-based inhibition motifs (ITIMs) and that, when tyrosyl-phosphorylated, recruit cytoplasmic SH2 domain-bearing protein tyrosine phosphatases (SHPs). ITIMs are borne by molecules that negatively regulate cell activation induced by receptors bearing immunoreceptor tyrosine-based activation motifs (ITAMs). Because SIRPalpha are coexpressed with ITAM-bearing receptors in hematopoietic cells, we investigated whether SIRPalpha could negatively regulate ITAM-dependent cell activation. We found SIRPalpha transcripts in human mast cells, and we show that a chimeric molecule having the transmembrane and intracytoplasmic domains of SIRPalpha could inhibit IgE-induced mediator secretion and cytokine synthesis by mast cells. Inhibition required that the SIRPalpha chimera was coaggregated with ITAM-bearing high affinity IgE receptors (FcepsilonRI). It was correlated with the tyrosyl phosphorylation of the SIRPalpha chimera and the recruitment of SHP-1 and SHP-2. The phosphorylation of FcepsilonRI ITAMs was decreased; the mobilization of intracellular Ca(2+) and the influx of extracellular Ca(2+) were reduced, and the activation of the mitogen-activated protein kinases Erk1 and Erk2 was abolished. SIRPalpha can therefore negatively regulate not only receptor tyrosine kinase-dependent cell proliferation but also ITAM-dependent cell activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10542295     DOI: 10.1074/jbc.274.45.32493

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B.

Authors:  T Uehara; M Bléry; D W Kang; C C Chen; L H Ho; G L Gartland; F T Liu; E Vivier; M D Cooper; H Kubagawa
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 2.  Mast cell regulation via paired immunoglobulin-like receptor PIR-B.

Authors:  Ching-Cheng Chen; Dong-Won Kong; Max D Cooper; Hiromi Kubagawa
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Role of CD47 and Signal Regulatory Protein Alpha (SIRPα) in Regulating the Clearance of Viable or Aged Blood Cells.

Authors:  Oldenborg Per-Arne
Journal:  Transfus Med Hemother       Date:  2012-09-17       Impact factor: 3.747

4.  An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions.

Authors:  Kaori Hitomi; Satoko Tahara-Hanaoka; Satoru Someya; Akira Fujiki; Hideaki Tada; Tetsuya Sugiyama; Shiro Shibayama; Kazuko Shibuya; Akira Shibuya
Journal:  Nat Immunol       Date:  2010-06-06       Impact factor: 25.606

5.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1.

Authors:  O Kassel; A Sancono; J Krätzschmar; B Kreft; M Stassen; A C Cato
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 6.  Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.

Authors:  Peter Valent; Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Michel Arock
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

Review 7.  Immunoglobulin E receptor signaling and asthma.

Authors:  Lawren C Wu
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

8.  CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.

Authors:  P A Oldenborg; H D Gresham; F P Lindberg
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

Review 9.  Macrophages are critical effectors of antibody therapies for cancer.

Authors:  Kipp Weiskopf; Irving L Weissman
Journal:  MAbs       Date:  2015       Impact factor: 5.857

10.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.